Asian Oceanian Congress of Child Neurology 17th AOCCN 2025

80 $

+ Include:  videos, size:  GB

+ Target Audience: Pediatric Neurologists, Pediatricians, Neurogeneticists, Neurosurgeons, Neuroimmunologists

Description

+ Include:  videos, size:  GB

+ Target Audience: Pediatric Neurologists, Pediatricians, Neurogeneticists, Neurosurgeons, Neuroimmunologists

+ Sample video: contact me for sample video

+ Information:

The 17th Asian Oceanian Congress of Child Neurology (AOCCN) is scheduled to be held from September 17 to 20, 2025, at the YASHOBHOOMI – India International Convention and Expo Centre in New Delhi, India. The congress aims to amalgamate technological advances and groundbreaking innovations with current clinical practices in child neurology, providing a global perspective with strong relevance to the Asia-Oceanic region. The event will feature parallel sessions, pre-conference and post-conference workshops, poster and podium presentations, and cultural activities, expecting over 2,000 national and international delegates.

Learning Objectives

  • To explore and integrate technological advances and digital innovations, including AI, in the management and diagnosis of pediatric neurological disorders.

  • To analyze the clinical, neuroimaging, and genetic aspects of complex neurodevelopmental disorders, such as autism spectrum disorders, cerebral palsy, and leukodystrophies.

  • To evaluate current and novel therapeutic approaches for pediatric epilepsies, including developmental and epileptic encephalopathies, drug-refractory epilepsy, and dietary/neuromodulation therapies.

  • To understand the evolving genetic landscape and precision medicine applications in childhood neurological disorders, including neuromuscular diseases and neurometabolic disorders.

  • To develop strategies for managing acute pediatric neurological emergencies, neurocritical care, and neuroinfections.

Target Audience

  • The conference will be attended by over 2000 national and international delegates and eminent international stalwarts, academicians, and researchers as expert faculty.
  • Best for Pediatric Neurologists, Pediatricians, Neurogeneticists, Neurosurgeons, and Neuroimmunologists.

Topics

  • Pre-Conference Workshops

    • Decoding the Phenomenology of Pediatric Movement Disorders

    • Understanding Pediatric Sleep Medicine Armamentorium

    • Demystifying Cytomolecular Genetics for Pediatric Neurologists

    • Ketogenic Diet in Pediatric Neurology Current Trends and Way Forward

    • Clinical Applications of Neuromodulation

    • Understanding the Enigma of Autism Spectrum Disorder

    • Changing Paradigms in the Management of Neuromuscular Disorders

    • New Frontiers in Neuroimmunology

  • Day 1

    • E-POSTER PRESENTATIONS Young Members – Meet & Greet

    • Inauguration Ceremony

    • Plenary Talk

    • Plenary Symposium

    • Prof. Fukuyama Memorial Oration

    • Hall A: Converging networks and approachments to autism and epilepsy with movement disorders; Debates; Developmental and Epileptic Encephalopathies (DEEs) – Concepts, Current and Novel Therapeutic Approaches; Drug Refractory Epilepsy; Immune-Mediated Pathways in Autism and other neurodevelopmental disorders; AFTERNOON SESSION – PART I; AFTERNOON SESSION – PART II.

    • Hall B: Autism Spectrum Disorders; Cerebral Palsy; Emerging genetic and therapeutic landscape in children with MeCP2 related disorders; Hot Topics in Neurology; Leukodystrophies in Pediatric Patients, clinical, neuroimaging, genetic; Platform presentations.

    • Hall C: Case-based approach to neurological emergencies in pediatrics; Current Pediatric Neurology – Snapshots; Emerging concepts in management of Sodium Channelopathies – Dravet syndrome and beyond; Infantile Epilepsy Syndromes (IESs) and Infantile Epileptic Spasm Syndrome (IESS); Neurocritical Care; Platform presentations.

    • Hall D: Autism and the Adolescent Brain Optimizing Psychiatric and Behavioural Outcomes through Medical Management VIDEO NOT RELEASE; Fever, Inflammation, and Epilepsy Encephalopathy VIDEO NOT RELEASE; Neuroinfections; Platform presentations; The pearls in diagnosis of cerebellar disorders; Video Quest.

  • Day 2

    • CULTURAL PROGRAM & GALA DINNER

    • Plenary Talk

    • Plenary Symposium

    • LUNCH-EON SYMPOSIUM

    • Hall A: Debates; Early beginnings and lifelong impact Navigating neurological challenges in the fetus and newborn; Ketogenic dietary therapies for epilepsy in diverse resource settings; Neurogenetics; Tech-driven innovations for managing epilepsy in children From schools to communities and clinics; AFTERNOON SESSION.

    • Hall B: Hot Topics in Neurology; Pediatric Headache; Phenylketonuria in 21st century From newborn screening to novel treatments; Platform presentations; Transitional and Palliative Care in Child Neurology; Vitamins and cofactorsresponsive childhood neurological disorders.

    • Hall C: An update on presurgical evaluation in a child with Drug Resistant Epilepsy; Cerebral Palsy; Challenges in Transforming Child Neurology with IGAP Unified Efforts in Asian-Oceanian Countries; Current Pediatric Neurology Snapshots; Oculomotor involvement in Acute Pediatric Neurological disorders; Platform presentations.

    • Hall D: 3Cs of Status Epilepticus Consensus, Controversies and Confusions; Beyond the blow Neuroplasticity and Predictors of recovery in pediatric traumatic brain injury; Innovations and Future Directions in Non Genetic Drug-Resistant Epilepsies; Pediatric Stroke; Platform presentations; Video Quest.

  • Day 3

    • Plenary Talk

    • Plenary Symposium

    • Lunch-eon Symposium “Empowering patients in SMA” by ROCHE

    • Legal Issues in Medical Practice Current perspectives

    • Hall A: Debates; Evolving therapies for muscular dystrophies Beyond dystrophinopathies; Neuromuscular Disorders; NeuroTech Frontiers Harnessing AI and Digital Innovation in Pediatric Neurology; Recent Advances in the Treatment of Drug Resistant Epilepsy; Afternoon Session – Part I; Afternoon Session – Part II.

    • Hall B: A multidimensional symposium on pediatric movement disorders A bird’s eye view; Cannabidiol in childhood epilepsy – Current status and future challenges for the AsiaOceania region; Little Minds, Big Challenges Pediatric Neurology Quiz; Pediatric Neuromodulation; Platform presentations; Responsive neurostimulation device therapy in children with refractory epilepsy.

    • Hall C: Consensus guidelines of MOGAD; Current Pediatric Neurology – Snapshots; Feeding the Developing Brain Nutrition in Child Neurology; Pediatric Neuroimmunology; Platform presentations; Precision Medicine and Challenges in Hereditary Neuromuscular Diseases.

    • Hall D: Advances in Pediatric Neurorehabilitation Restoring Function, Empowering Futures; From Variant to Verdict Interpreting Genetic Reports in Child Neurology Practice; Pediatric Movement Disorders & Epilepsy; Platform presentations; Targeting the tumbles New horizons in management of inherited ataxias; Video Quest.

  • Day 4

    • Plenary Talk

    • Hall A: Intersecting Spectrums Clinical and Neurobiological Interfaces of Autism and Epilepsy; Neurocutaneous Syndromes From Skin Clues to Brain Insights; Supporting children with developmental disabilities in low-income contexts.

    • Hall B: Charot-Marie-Tooth Disease a stroll through advances in diagnosis and management; Dietary therapies in Pediatric Neurology Beyond Epilepsy; Sensory pathways at the crossroads – Integrating vision and hearing in neurological disorders.

    • Hall C: An overview of novel treatable neurometabolic disorders; Ethics, Research & Publications in Child Neurology; Navigating the Wave of Next-Generation Sequencing.

    • Hall D: Genomics in neurology training is it a boon or bane; Neonatal Seizure Current approachments and novel modalities; Pediatric Neurooncology Innovations in Diagnosis, Treatment, and Survivorship.

  • Post-Conference Workshops

    • Current Pediatric Neurology for the Pediatricians

Reviews

There are no reviews yet.

Be the first to review “Asian Oceanian Congress of Child Neurology 17th AOCCN 2025”

Your email address will not be published. Required fields are marked *

50 − 41 =
Powered by MathCaptcha